106
Views
10
CrossRef citations to date
0
Altmetric
Original Research

A MSLN-targeted multifunctional nanoimmunoliposome for MRI and targeting therapy in pancreatic cancer

, , , , , , , & show all
Pages 5053-5065 | Published online: 19 Sep 2012

References

  • JemalABrayFCenterMMFerlayJWardEFormanDGlobal cancer statisticsCA Cancer J Clin2011612699021296855
  • PliarchopoulouKPectasidesDPancreatic cancer: current and future treatment strategiesCancer Treat Rev20093543143619328630
  • ArganiPIacobuzio-DonahueCRyuBMesothelin is overexpressed in the vast majority of ductal adenocarcinomas of the pancreas: identification of a new pancreatic cancer marker by serial analysis of gene expression (SAGE)Clin Cancer Res200173862386211751476
  • OrdóñezNGApplication of mesothelin immunostaining in tumor diagnosisAm J Surg Pathol2003271418142814576474
  • RoeODCreaneyJLundgrenSMesothelin-related predictive and prognostic factors in malignant mesothelioma: a nested case-control studyLung Cancer20086123524318281122
  • HassanRBeraTPastanIMesothelin: a new target for immunotherapyClin Cancer Res20041012 Pt 13937394215217923
  • SumerBGaoJTheranostic nanomedicine for cancerNanomedicine (Lond)20083213714018373419
  • SunCLeeJSZhangMMagnetic nanoparticles in MR imaging and drug deliveryAdv Drug Deliv Rev2008601252126518558452
  • Di MarcoMSadunCPortMGuilbertICouvreurPDubernetCPhysicochemical characterization of ultrasmall superparamagnetic iron oxide particles (USPIO) for biomedical application as MRI contrast agentsInt J Nanomedicine2007260962218203428
  • YangCRaitAPirolloKFDagataJAFarkasNChangEHNanoimmunoliposome delivery of superparamagnetic iron oxide markedly enhances targeting and uptake in human cancer cells in vitro and in vivoNanomedicine2008431832918676207
  • KozlowskaDForanPMacMahonPShellyMJEustaceSO’KennedyRMolecular and magnetic resonance imaging: The value of immunoliposomesAdv Drug Deliv Rev2009611402141119796661
  • TorchilinVPRecent advances with liposomes as pharmaceutical carriersNat Rev Drug Discov2005414516015688077
  • FrascioneDDiwokyCAlmerGUltrasmall superparamagnetic iron oxide (USPIO)-based liposomes as magnetic resonance imaging probesInt J Nanomedicine201272349235922661890
  • MaruyamaKIntracellular targeting delivery of liposomal drugs to solid tumors based on EPR effectsAdv Drug Deliv Rev20116316116920869415
  • YoshizawaYKonoYOgawaraKKimuraTHigakiKPEG liposomalization of paclitaxel improved its in vivo disposition and anti-tumor efficacyInt J Pharm20114121–213214121507344
  • DassCRChoongPFTargeting of small molecule anticancer drugs to the tumour and its vasculature using cationic liposomes: lessons from gene therapyCancer Cell Int200661716792817
  • MeldrumKKBurnettALMengXLiposomal delivery of heat shock protein 72 into renal tubular cells blocks nuclear factor-kappaB activation, tumor necrosis factor-alpha production, and subsequent ischemia-induced apoptosisCirc Res20039229329912595341
  • TorchilinVPRammohanRWeissigVLevchenkoTSTAT peptide on the surface of liposomes affords their efficient intracellular delivery even at low temperature and in the presence of metabolic inhibitorsProc Natl Acad Sci U S A2001988786879111438707
  • ReimerDLKongSMonckMLiposomal lipid and plasmid DNA delivery to B16/BL6 tumors after intraperitoneal administration of cationic liposome DNA aggregatesJ Pharmacol Exp Ther199928980781510215656
  • GaoJYuYZhangYEGFR-specific PEGylated immunoliposomes for active siRNA delivery in hepatocellular carcinomaBiomaterials20123327028221963149
  • BogdanovAAJrMartinCWeisslederRBradyTJTrapping of dextran-coated colloids in liposomes by transient binding to aminophospholipid: preparation of ferrosomesBiochim Biophys Acta199411932122187518693
  • LuJJeonELeeBSOnyukselHWangZJTargeted drug delivery crossing cytoplasmic membranes of intended cells via ligand-grafted sterically stabilized liposomesJ Control Release200611050551316356575
  • SaulJMAnnapragadaANatarajanJVBellamkondaRVControlled targeting of liposomal doxorubicin via the folate receptor in vitroJ Control Release2003921–2496714499185
  • KiwadaHSatoJYamadaSKatoYFeasibility of magnetic liposomes as a targeting device for drugsChem Pharm Bull (Tokyo)198634425342583829157
  • HeathTDRobertsonDBirbeckMSDaviesAJCovalent attachment of horseradish peroxidase to the outer surface of liposomesBiochim Biophys Acta198059942627397158
  • SkourasAMourtasSMarkoutsaEMagnetoliposomes with high USPIO entrapping efficiency, stability and magnetic propertiesNanomedicine2011757257921704597
  • KlibanovALMaruyamaKBeckerlegAMTorchilinVPHuangLActivity of amphipathic poly(ethylene glycol) 5000 to prolong the circulation time of liposomes depends on the liposome size and is unfavorable for immunoliposome binding to targetBiochim Biophys Acta199110621421482004104
  • MoriMLiuDKumarSHuangZNMR structures of anti-HIV D-peptides derived from the N-terminus of viral chemokine vMIP-IIBiochem Biophys Res Commun200533565165816115468
  • TorchilinVPTargeted pharmaceutical nanocarriers for cancer therapy and imagingAAPS J20079E128E14717614355
  • BolotinEMCohenRBarLKAmmonium sulfate gradients for efficient and stable remote loading of amphipathic weak bases into liposomes and ligandoliposomesJ Liposome Res19944455479
  • SoenenSJHodeniusMDe CuyperMMagnetoliposomes: versatile innovative nanocolloids for use in biotechnology and biomedicineNanomedicine (Lond)2009417719119193184
  • MulderWJStrijkersGJGriffioenAWA liposomal system for contrast-enhanced magnetic resonance imaging of molecular targetsBioconjug Chem20041579980615264867